NASDAQ:ABEO
Abeona Therapeutics Inc. Stock News
$4.45
+0.0500 (+1.14%)
At Close: May 09, 2024
A Fake Raid, A Fake Village And A Sinking Track
03:31pm, Thursday, 30'th Jul 2020
A detailed look travelling inside an AAV built to go from sea to shore.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
4D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, annou
Forge Biologics Launches with $40 Million Series A Financing to Manufacture and Develop Gene Therapies
11:25am, Tuesday, 21'st Jul 2020
Press Release Forge Biologics, a viral vector gene therapy manufacturing and development company with the dual platform of CDMO capabilities and the development of proprietary gene therapy products, t
Critical Review: Abeona Therapeutics (NASDAQ:ABEO) versus Cyclerion Therapeutics (NASDAQ:FBRX)
01:06am, Sunday, 19'th Jul 2020
Abeona Therapeutics (NASDAQ:ABEO) and Cyclerion Therapeutics (NASDAQ:FBRX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the str
Abeona Therapeutics (NASDAQ:ABEO) Given “Buy” Rating at HC Wainwright
08:20am, Monday, 13'th Jul 2020
Abeona Therapeutics (NASDAQ:ABEO)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Monday, AnalystRatings.com reports. They presently have a
AQR Capital Management LLC Purchases New Shares in Abeona Therapeutics Inc (NASDAQ:ABEO)
04:06am, Sunday, 12'th Jul 2020
AQR Capital Management LLC purchased a new stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commi
EB-101 treatment of large, chronic wounds is associated with durable healing and pain relief in patients with RDEBLiterature review of 65 studies confirms and expands.
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
12:00am, Friday, 10'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 9)
Affimed NV (NASDAQ: AFMD)...
Abeona Restarts Enrollment in Connective Tissue Disorder Study
01:10pm, Thursday, 09'th Jul 2020
Abeona (ABEO) restarts patient enrollment in phase III VIITAL study of EB-101 for the treatment of recessive dystrophic epidermolysis bullosa.
Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Commercial Officer
11:30am, Thursday, 09'th Jul 2020
NEW YORK and CLEVELAND, July 09, 2020 -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Michael.
3 “Perfect 10” Healthcare Stocks That Have Plenty Of Growth On Tap
12:00am, Thursday, 09'th Jul 2020
Stocks Analysis by Investing Insights covering: ChemoCentryx Inc, United Therapeutics Corporation, Axsome Therapeutics Inc. Read Investing Insights 's latest article on Investing.com
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced recent updates on its clinical programs, highlighted by the restart of patient enrollment in the Co
With Its Film Fest Postponed by the Pandemic, Rare-Disease Group Starts Its Own Streaming Channel
12:00am, Wednesday, 08'th Jul 2020
Rare Outreach Coalition has launched The Disorder Channel to showcase rare disease films and videos for free on Roku® and Amazon Fire TV.
Here's Why We're Watching Abeona Therapeutics's (NASDAQ:ABEO) Cash Burn Situation
11:48am, Friday, 03'rd Jul 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although...
